Full form of 6-MP is 6-MercaptoPurine

6-MercaptoPurine, commonly abbreviated as 6-MP, is a chemotherapy medication used primarily in the treatment of acute lymphoblastic leukemia (ALL) and other types of leukemia. It belongs to a class of drugs known as antimetabolites, which work by interfering with the growth of cancer cells. By disrupting the DNA of these cells, 6-MP effectively slows down or halts their proliferation, making it an essential component of cancer treatment regimens.

In the medical field, 6-MercaptoPurine is often prescribed in combination with other medications to enhance its effectiveness. Its use extends to managing certain autoimmune diseases due to its immunosuppressive properties. Physicians carefully monitor dosages and patient responses to minimize potential side effects, highlighting the importance of medical oversight when using 6-MP.

Understanding the role of 6-MP in treatment protocols is crucial for healthcare professionals and patients alike. It remains a vital tool in oncology, contributing significantly to the management and survival rates of patients with certain cancers. Its application in medicine underscores the ongoing advancements in cancer therapy and the importance of precise treatment strategies.